CCSD code 25150 – Trigeminal ganglion injection

Key takeaways

CCSD Code 25150 covers trigeminal ganglion injection with local anaesthetic under X-ray control only. Neurolytic injections and unguided procedures use different codes.

Fluoroscopic guidance is mandatory, so without X-ray control the procedure cannot be billed as 25150, whatever anaesthetic agent was used.

Most UK private medical insurers, including Bupa, AXA Health and Aviva, require prior authorisation first. The usual primary diagnosis is ICD-10 G50.0, trigeminal neuralgia.

A sphenopalatine block or a diagnostic block of a trigeminal branch is coded A7350, not 25150.

Practice management software like Pabau keeps the CCSD code, insurer fees and the operative note in one workflow. Each claim is then prepared from one patient record.

CCSD Code 25150: definition and quick-reference guide

CCSD Code 25150 is defined in the Clinical Coding and Schedule Development (CCSD) schedule as Trigeminal ganglion injection (local anaesthetic under X-ray control). The code applies when a clinician injects a local anaesthetic into the trigeminal (Gasserian) ganglion, with real-time fluoroscopy confirming needle placement. Each part of that descriptor is a billing condition. Change any one of them and the procedure moves to a different code, as the check below shows.

CCSD is a UK-specific coding system maintained by the CCSD Group. Four major private medical insurers make up the group: Bupa, Vitality, AXA Health and Aviva. Practices use it only in the independent and private healthcare sector. NHS providers do not use CCSD codes.

How trigeminal ganglion injection is performed under X-ray control

Trigeminal ganglion injection is a percutaneous procedure performed by an anaesthetist or interventional pain consultant, with the patient supine under fluoroscopic control. The technique explains why image guidance is inseparable from both the procedure and the billing code.

1. Patient positioning and consent: The patient lies supine with the neck slightly extended. The clinician obtains written consent for a fluoroscopy-guided interventional procedure beforehand, and the operative note records the consent reference.
2. Fluoroscopic target identification: The clinician positions the C-arm to visualise the foramen ovale at the skull base. The foramen ovale is the anatomical corridor the needle passes through to reach the trigeminal (Gasserian) ganglion. Real-time imaging confirms the approach trajectory before needle insertion.
3. Needle passage through the foramen ovale: The clinician advances a spinal-type needle percutaneously under continuous fluoroscopic guidance through the foramen ovale, then confirms the needle tip position in both anteroposterior and lateral projections.
4. Contrast injection and confirmation: A small volume of contrast medium confirms intraganglionic or periganglionic placement and excludes an intravascular or intrathecal needle position. The operative note records the contrast agent name and volume.
5. Local anaesthetic deposition: Once the clinician confirms placement, they slowly deposit the local anaesthetic (typically lidocaine or bupivacaine). The operative note records the agent, concentration and volume injected.

Fluoroscopy is a patient safety requirement, because the needle has to be placed accurately at the skull base. That same requirement decides code eligibility. A clinician who performs the injection without fluoroscopic guidance cannot bill CCSD Code 25150, whatever the clinical indication or anaesthetic agent.

Clinical indications for trigeminal ganglion injection

The procedure treats facial pain conditions where the trigeminal nerve pathway is the anatomical target. Referral letters and operative notes should document the specific indication, since insurers may request it during prior authorisation or claim assessment. In pain medicine, prior authorisation criteria typically hinge on documented evidence of failed conservative treatment.

• Trigeminal neuralgia (ICD-10 G50.0): The primary indication, marked by episodes of severe, electric-shock facial pain along one or more branches of the trigeminal nerve. The treating clinician should confirm the most accurate ICD-10 code, since atypical presentations may map to G50.1 or G50.8.
• Refractory atypical facial pain: Persistent facial pain unresponsive to pharmacological management, where a trigeminal pathway contribution has been identified.
• Diagnostic nerve block prior to neurolysis or surgery: A local anaesthetic block can predict the effect of a more permanent neurolytic intervention or surgical decompression. It confirms the trigeminal ganglion as the pain generator.
• Failed conservative therapy: Most insurers require documented evidence of at least two pharmacological treatments (carbamazepine, oxcarbazepine, or alternatives) before approving an interventional procedure.

Clinical decisions about patient suitability and contraindications rest entirely with the treating clinician. This article covers billing and coding only.

What the code includes and excludes

The descriptor boundary is precise. A code that does not match the procedure exactly is the most correctable cause of claim denial. Check the inclusions and exclusions below against the operative note before submission.

Neighbouring CCSD codes and how 25150 differs

Several adjacent CCSD codes cover interventional pain procedures at nearby sites or with different agents. The right code depends on the injection site, the agent used and whether imaging guidance was employed. Verify current descriptors against the official CCSD schedule before billing, since descriptors and code boundaries are revised periodically.

A sphenopalatine block or a diagnostic block of a single trigeminal branch is billed as A7350, not 25150. The summaries above are for orientation only, so check the full descriptor in the current schedule before you code.

Why X-ray control is a billing requirement

The words “under X-ray control” make fluoroscopic guidance a billing criterion for CCSD Code 25150. A procedure performed without real-time X-ray imaging cannot be billed under this code, even if the correct ganglion and the correct anaesthetic agent were used.

Whether the radiological supervision element can be coded separately depends on who performs and reports the imaging. If a radiologist separately performs and reports the fluoroscopic supervision, that radiologist may be able to bill a radiology supervision code.

If the anaesthetist uses fluoroscopy as part of their own technique, insurers generally consider it bundled within CCSD Code 25150. Insurers differ on this point. Confirm the co-billing position with each insurer, or ask the CCSD technical helpdesk, before billing a separate radiology code.

Documentation requirements for CCSD Code 25150 claims

A complete claim file for CCSD Code 25150 shows that the procedure matches the descriptor at every point. Digital clinical documentation that captures the required fields at the point of procedure lowers the risk of a missing-documentation denial. The claim file should hold these items before submission.

• Referral letter with confirmed diagnosis: The referring clinician’s letter must state the diagnosis (ICD-10 G50.0 for trigeminal neuralgia, or the clinically accurate alternative). It must also confirm the indication for an interventional procedure.
• Operative note confirming the procedure: It must document the anatomical target (trigeminal ganglion, foramen ovale approach). It must also name the local anaesthetic, with its concentration and volume. It must also state explicitly that fluoroscopic guidance was used.
• Fluoroscopy record: The imaging system used, the contrast agent name and volume, and the screening time or image count if the insurer contract requires it.
• Patient consent record: Signed consent for an image-guided interventional pain procedure, including risk disclosure.
• Prior authorisation reference number: If pre-approval was obtained, the authorisation reference must appear on the invoice and the claim. Insurers will deny a claim without a valid PA reference, even if the clinician performed and documented the procedure correctly.
• Invoice with CCSD Code 25150: The invoice must state the code number, the official descriptor and the procedure date. It also needs the treating clinician’s name and GMC number, and the facility name.

A pre-submission checklist for interventional pain procedures lets practice managers confirm each item is captured before the claim goes out. That is far quicker than chasing missing documents after a denial arrives. Referral requirements also vary by insurer, so confirm them with each payer when onboarding new consultants.

Prior authorisation: what insurers require

UK private medical insurers typically require prior authorisation (PA) before a trigeminal ganglion injection. Authorisation is a condition of reimbursement. A procedure performed before it is granted may be denied, even when it was clinically appropriate and correctly coded.

PA criteria change, so verify them directly with each insurer. The requirements below are typical and must be checked against each insurer’s current guidance.

Facility accreditation is a common sticking point. Independent-sector facilities in England must hold CQC registration, and some insurers check it as part of their provider recognition criteria. Confirm your facility’s recognition status with each insurer when you onboard a new procedure.

Common reasons 25150 claims are denied

CCSD Code 25150 denials usually trace back to one of six causes. Each has a straightforward fix, provided the procedure was performed correctly and documented in full.

• No imaging guidance documented: The operative note does not reference fluoroscopy, contrast confirmation, or the imaging system used. Fix: Amend the operative note with the specific imaging details and resubmit. Do not resubmit without clinical evidence supporting the amendment.
• Neurolytic agent billed as 25150: The operative note records glycerol, phenol or alcohol. That makes it a neurolytic procedure under a different CCSD code. Fix: Recode to the correct neurolytic procedure code and resubmit. Never bill 25150 for a neurolytic injection.
• Missing or expired prior authorisation: The claim lacks a valid PA reference number, or the authorisation has lapsed. Fix: Ask the insurer for retrospective authorisation, which is rarely granted. Document why PA was not obtained before the procedure to support any appeal.
• Incorrect diagnosis code on the claim: The ICD-10 code on the invoice does not align with the clinical indication or the PA reference. Fix: Confirm the correct ICD-10 code with the treating clinician and resubmit with a corrected invoice.
• Procedure performed by an unrecognised provider: The insurer does not recognise the clinician for this procedure, or the facility is not on its approved list. Fix: Verify recognition status with the insurer before booking the procedure. Escalate to the insurer’s provider relations team if recognition is recorded incorrectly.
• Claim submitted outside the insurer’s timescale: Most UK insurers require claims within three to six months of the procedure date. Fix: Submit claims promptly, and use practice management software to trigger a billing alert on the day of the procedure.

Reimbursement and fee schedules for 25150

CCSD fee schedules are negotiated individually between each insurer and recognised providers, so published rates are commercially sensitive and updated annually. Verify your current fee entitlement against your insurer contracts rather than relying on third-party estimates. The notes below are indicative sector context only.

For the most accurate reimbursement figures, log in to the Bupa code search portal, the Aviva fee schedule or your insurer’s provider portal. Our CCSD billing guides break down other codes in the schedule the same way, including the neighbouring nerve block codes.

How Pabau keeps CCSD Code 25150 claims complete

In many practices the code lives in one system, the insurer fees in a spreadsheet and the operative note somewhere else. Each hand-off is a chance for an invoice to go out at the wrong rate, or without the fluoroscopy details an insurer asks for.

Practice management software like Pabau stores the CCSD code, per-insurer fees and the clinical record against the same patient. Setting 25150 up once, before the first procedure, saves re-entering fee data and correcting invoices later. Pabau’s claims software for practices then tracks each claim after submission. To set the code up:

1. Create the service entry: Create a new procedure with the code 25150. Enter the official descriptor verbatim: Trigeminal ganglion injection (local anaesthetic under X-ray control). Matching the descriptor exactly prevents invoice discrepancies.
2. Set per-insurer fees: Enter the negotiated fee for each insurer separately (Bupa, AXA Health, Aviva, WPA, and others). Fee schedules differ, so a single default fee across all insurers leads to payment shortfalls.
3. Link to the invoice template: Attach the code to the right invoice template. The code number, descriptor and treating clinician details then fill in automatically.
4. Add a prior-auth reminder: Configure a workflow trigger that flags the PA requirement whenever 25150 is selected for an appointment. It catches missing authorisation before the procedure date, not after a denial.
5. Attach clinical documentation: Link the operative note template to the service code, so the procedure record sits in the same workflow. The imaging documentation then stays with the invoice, which makes insurer document requests quicker to answer.

Manage CCSD billing with Pabau

Store CCSD codes, insurer-specific fees and clinical notes in one place. Each 25150 claim then goes out with the right code, fee and authorisation reference.

Book a demo

Conclusion

Before billing 25150, read the operative note against the descriptor: local anaesthetic, trigeminal ganglion, X-ray control. If one element is missing or different, recode now. A denied claim costs a full resubmission cycle, and a correct code up front costs nothing extra.

The trade-off is a few extra minutes of documentation at the procedure. Recording the agent, the fluoroscopy details and the PA reference saves weeks of chasing payment later. Book a demo to see how Pabau keeps CCSD codes, insurer fees and procedure notes together for UK private practices.

Continue your research

Need guidance on Bupa’s CCSD coding requirements? Bupa CCSD codes reference covers Bupa-specific code lists, fee structures and submission requirements for UK private practice.

Billing a block at the dorsal root ganglion instead? CCSD code 25120: dorsal root ganglion block explains how one code covers both local anaesthetic and neurolytic agents.

Checking Bupa’s fees for a procedure? Bupa procedure codes and fee schedule collects Bupa’s codes and fee guidance in one place.

Frequently asked questions